CClinicalTrials.gg
CompletedNCT05372770Updated Jul 1, 2025

Flourish Vaginal Care System to Establish Neovaginal Microbiome

An interventional study of Flourish Vaginal Care system in Neovaginal Microbiome, sponsored by Vaginal Biome Science. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-01.

Sponsored by Vaginal Biome Science · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was Jul 2024, 2 years 3 months ago, and no results have been posted to the registry.
  • Registered 3 months after the study started (first participant enrolled Jan 2022, registered May 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study examines whether use of a commercially-available vaginal wellness system is able to establish a microbiome in transgender women.

Read the detailed description

Very little is known about the neovaginal microbiome, but it has been described as being a polymicrobial state similar to bacterial vaginosis (BV) in cis women. The Flourish Vaginal Care System is a commercially-available over-the-counter vaginal wellness kit that helps relieve symptoms of BV. This study is intended to determine whether that kit could also help transgender women who have recently undergone gender-confirming surgery to establish a neovaginal microbiome that is dominated by lactobacilli, as observed in healthy cis women. This could increase health and subjective satisfaction of the neovagina. This study examines the (neo)vaginal microbiome in transgender women with and without using Flourish, as well as a group of healthy cisgender women.

02

Conditions studied

  • Neovaginal Microbiome

Keywords

  • neovagina
  • microbiome
  • lactobacillus
  • transgender
  • probiotic
03

In context

Lead sponsor

Vaginal Biome Science is the lead sponsor of 10 studies on the registry; 1 is open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Transgender women over age 18 who are preparing to undergo gender-confirmation surgery.
  2. Healthy cisgender women ages 18-52

Exclusion criteria

Exclusion Criteria:

  1. Immunosuppressed
  2. Known allergies or sensitivities to aloe vera or to other components of Restore®, Balance, or BiopHresh®
  3. Known (neo)vaginal infection that is not yeast or BV at start of protocol
  4. Inability to tolerate Restore gel by day 13 after surgery.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    Group 1: Transgender women using Flourish

    After gender-confirming surgery, this group will use the Flourish Vaginal Care System for six months, ramping up usage with healing. They will use "Balance" external wash beginning day 6 after surgery; "Restore®" vaginal moisturizing gel on dilators beginning day 6 after surgery; Restore every other day at bedtime with "BiopHresh" homeopathic/probiotic suppository every 3rd day at bedtime beginning week 6 after surgery through end of study at 6 months.

    Device: Flourish Vaginal Care system

  • No intervention
    Group 2: Transgender women not using Flourish

    After gender-confirming surgery, this group will use only KY jelly on dilators beginning day 6 after surgery according to routine care; they will use any standard hygiene product (soap, body wash, etc) of their choice except products used by Group 1 through the end of the study at 6 months.

  • Other
    Group 3: Cisgender women

    This group will use the Flourish Vaginal Care system for 6 months: Balance external wash daily; Restore intravaginal gel every other day at bedtime; BiopHresh homeopathic/probiotic suppository every 3rd day at bedtime through the end of study.

    Device: Flourish Vaginal Care system

Interventions

  • DeviceFlourish Vaginal Care system

    Flourish includes Restore® vaginal moisturizing gel, a Class II medical device cleared by the FDA, in addition to two other kit components

06

What researchers measure

Primary outcomes

  1. Vaginal microbiome

    Observation of changes in the composition of the vaginal fluid microbiome over six months using commercially available next-generation sequencing kit (16s rRNA). Biomes will be categorized to "community state type" (Ravel 2011), and genus- or species-level relative abundance will be compared.

    Time frame: Collections at time 0, 6 weeks, and 6 months

  2. Vaginal pH

    Observation of changes in vaginal pH over six months by pH strip

    Time frame: Collections at time 0, 6 weeks, and 6 months

Secondary outcomes

  1. VSQ

    Responses to the Vulvovaginal Symptoms Questionnaire

    Time frame: Collections at time 0, 6 weeks, and 6 months

07

Study locations

1 site
  • Papillon Wellness Center
    New Hope, Pennsylvania 18938, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05372770
Lead sponsor
Vaginal Biome Science
Responsible party
Sponsor
First posted
May 13, 2022
Start date
Jan 24, 2022
Primary completion
Jul 1, 2024
Completion
Dec 12, 2024
Last update
Jul 1, 2025

Study contacts

Christine McGinn, DO
principal investigator · Papillon Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion